Cargando…

Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO

Detalles Bibliográficos
Autores principales: Honore, Patrick M., Barreto Gutierrez, Leonel, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358299/
https://www.ncbi.nlm.nih.gov/pubmed/32660540
http://dx.doi.org/10.1186/s13054-020-03145-5
_version_ 1783558822575472640
author Honore, Patrick M.
Barreto Gutierrez, Leonel
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
De Bels, David
author_facet Honore, Patrick M.
Barreto Gutierrez, Leonel
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
De Bels, David
author_sort Honore, Patrick M.
collection PubMed
description
format Online
Article
Text
id pubmed-7358299
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73582992020-07-14 Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO Honore, Patrick M. Barreto Gutierrez, Leonel Kugener, Luc Redant, Sebastien Attou, Rachid Gallerani, Andrea De Bels, David Crit Care Letter BioMed Central 2020-07-13 /pmc/articles/PMC7358299/ /pubmed/32660540 http://dx.doi.org/10.1186/s13054-020-03145-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter
Honore, Patrick M.
Barreto Gutierrez, Leonel
Kugener, Luc
Redant, Sebastien
Attou, Rachid
Gallerani, Andrea
De Bels, David
Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
title Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
title_full Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
title_fullStr Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
title_full_unstemmed Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
title_short Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
title_sort use of multiple laboratory tests including anti-factor xa to optimally manage anticoagulation during ecmo
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358299/
https://www.ncbi.nlm.nih.gov/pubmed/32660540
http://dx.doi.org/10.1186/s13054-020-03145-5
work_keys_str_mv AT honorepatrickm useofmultiplelaboratorytestsincludingantifactorxatooptimallymanageanticoagulationduringecmo
AT barretogutierrezleonel useofmultiplelaboratorytestsincludingantifactorxatooptimallymanageanticoagulationduringecmo
AT kugenerluc useofmultiplelaboratorytestsincludingantifactorxatooptimallymanageanticoagulationduringecmo
AT redantsebastien useofmultiplelaboratorytestsincludingantifactorxatooptimallymanageanticoagulationduringecmo
AT attourachid useofmultiplelaboratorytestsincludingantifactorxatooptimallymanageanticoagulationduringecmo
AT galleraniandrea useofmultiplelaboratorytestsincludingantifactorxatooptimallymanageanticoagulationduringecmo
AT debelsdavid useofmultiplelaboratorytestsincludingantifactorxatooptimallymanageanticoagulationduringecmo